Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.32 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diethanolamine SCHEMBL5569921 | 0.88 | — | — | |
| SCHEMBL6931377 | 0.81 | MEN1 (0.39) | MAPT | |
| SCHEMBL14197152 | 0.80 | MLYCD (0.38) | CA12CA1CA2CA9MAPT | |
| SCHEMBL10451818 | 0.80 | CA12 (0.35) | CA12CA1CA2CA9 | |
| SCHEMBL1399124 | 0.78 | TP53 (0.35) | CA12CA1CA2CA9MAPT | |
| SCHEMBL18569530 | 0.77 | L3MBTL1 (0.48) | ALDH1A1 | |
| SCHEMBL4324459 | 0.76 | CA12 (0.32) | CA12CA1CA2CA9MAPT | |
| SCHEMBL2921860 | 0.75 | LMNA (0.39) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL10671732 | 0.75 | LMNA (0.39) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL10673924 | 0.75 | LMNA (0.39) | CA12CA1CA2CA9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7619050-B2 | Alkoxyamines containing a radically polymerizable group | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2009-11-17 | — | — | US | disclosed |
| EP-1749032-B1 | ALKOXYAMINES CONTAINING A RADICALLY POLYMERIZABLE GROUP | CIBA SC HOLDING AG (CH) | 2008-02-27 | — | — | EP | disclosed |
| US-20070232768-A1 | Alkoxyamines Containing a Radically Polymerizable Group | CIBA SPECIALTY CHEMICALS CORP. | 2007-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070232768-A1 | Alkoxyamines Containing a Radically Polymerizable Group | ALKBH3, ALKBH2, ALKBH5 | CA12 4645/4885CA1 4834/4885CA2 4685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.